Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Net Margin (2016 - 2025)

Apyx Medical (APYX) has disclosed Net Margin for 15 consecutive years, with 6.78% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin rose 2576.0% year-over-year to 6.78%, compared with a TTM value of 21.22% through Dec 2025, up 2756.0%, and an annual FY2025 reading of 21.22%, up 2756.0% over the prior year.
  • Net Margin was 6.78% for Q4 2025 at Apyx Medical, up from 15.41% in the prior quarter.
  • Across five years, Net Margin topped out at 6.78% in Q4 2025 and bottomed at 73.96% in Q1 2024.
  • Average Net Margin over 5 years is 39.75%, with a median of 39.99% recorded in 2023.
  • The sharpest move saw Net Margin soared 7308bps in 2021, then tumbled -4645bps in 2024.
  • Year by year, Net Margin stood at 11.95% in 2021, then plummeted by -303bps to 48.09% in 2022, then plummeted by -36bps to 65.52% in 2023, then skyrocketed by 50bps to 32.54% in 2024, then skyrocketed by 79bps to 6.78% in 2025.
  • Business Quant data shows Net Margin for APYX at 6.78% in Q4 2025, 15.41% in Q3 2025, and 33.22% in Q2 2025.